Position in VTRS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$60,799,755
+$16,663,136 QoQ
Shares Held
4,500,352
+26.9% QoQ
Ownership
0.386%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
19 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Gotham Asset Management, LLC holds $204,070,964 across 22 Drug Manufacturers - Specialty & Generic names. VTRS ranks #1 (29.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
This page
|
4,500,352 | $60,799,755 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
80,387 | $47,667,883 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
360,136 | $47,444,316 | |
| 4 | ZTS |
Zoetis Inc.
|
212,586 | $25,129,791 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
331,032 | $7,921,595 | |
| 6 | BCRX |
Biocryst Pharmaceuticals Inc
|
312,961 | $2,979,388 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
24,095 | $1,852,905 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
55,614 | $1,839,154 |
All Filings in VTRS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $60,799,755 | 4,500,352 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $44,136,619 | 3,545,110 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $33,172,048 | 3,350,712 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $24,196,808 | 2,709,609 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,094,347 | 814,506 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $18,922,269 | 1,519,861 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $15,401,686 | 1,326,588 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $10,342,660 | 972,969 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $9,088,477 | 761,179 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $6,608,715 | 610,223 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $7,625,724 | 773,400 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,379,229 | 539,001 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,667,057 | 381,191 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,708,677 | 512,909 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $7,841,254 | 920,335 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,336,778 | 414,210 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,500,291 | 321,718 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,086,310 | 80,289 | Shares | Sole | 2022-02-14 | |
| 2020-12-31 | $5,436,923 | 290,124 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||